Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7650875rdf:typepubmed:Citationlld:pubmed
pubmed-article:7650875lifeskim:mentionsumls-concept:C1882598lld:lifeskim
pubmed-article:7650875lifeskim:mentionsumls-concept:C0001455lld:lifeskim
pubmed-article:7650875lifeskim:mentionsumls-concept:C0071163lld:lifeskim
pubmed-article:7650875lifeskim:mentionsumls-concept:C0332161lld:lifeskim
pubmed-article:7650875lifeskim:mentionsumls-concept:C0220839lld:lifeskim
pubmed-article:7650875lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:7650875lifeskim:mentionsumls-concept:C1157645lld:lifeskim
pubmed-article:7650875lifeskim:mentionsumls-concept:C1519355lld:lifeskim
pubmed-article:7650875pubmed:issue4lld:pubmed
pubmed-article:7650875pubmed:dateCreated1995-9-26lld:pubmed
pubmed-article:7650875pubmed:abstractTextIn rat hippocampal slices, pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38) stimulated cyclic AMP formation in dose- and time-dependent manners. The PACAP-38 action was dose-dependently attenuated by L-glutamate in the hippocampus; L-glutamate at the concentration of 1 mM attenuated PACAP-38-stimulated cyclic AMP formation by approximately 30%. The inhibitory effect of L-glutamate is also observed in rat cerebellar slices. In contrast, the inhibitory effect of a prostanoid EP3-receptor agonist on PACAP-38-stimulated cyclic AMP formation was brain region-specific; the inhibitory action was observed in the cerebellum but not in the hippocampus.lld:pubmed
pubmed-article:7650875pubmed:languageenglld:pubmed
pubmed-article:7650875pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7650875pubmed:citationSubsetIMlld:pubmed
pubmed-article:7650875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7650875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7650875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7650875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7650875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7650875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7650875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7650875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7650875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7650875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7650875pubmed:statusMEDLINElld:pubmed
pubmed-article:7650875pubmed:monthAprlld:pubmed
pubmed-article:7650875pubmed:issn0021-5198lld:pubmed
pubmed-article:7650875pubmed:authorpubmed-author:HashimotoHHlld:pubmed
pubmed-article:7650875pubmed:authorpubmed-author:BabaAAlld:pubmed
pubmed-article:7650875pubmed:authorpubmed-author:KondoKKlld:pubmed
pubmed-article:7650875pubmed:authorpubmed-author:SakataKKlld:pubmed
pubmed-article:7650875pubmed:authorpubmed-author:KitanakaJJlld:pubmed
pubmed-article:7650875pubmed:authorpubmed-author:SageLLlld:pubmed
pubmed-article:7650875pubmed:issnTypePrintlld:pubmed
pubmed-article:7650875pubmed:volume67lld:pubmed
pubmed-article:7650875pubmed:ownerNLMlld:pubmed
pubmed-article:7650875pubmed:authorsCompleteYlld:pubmed
pubmed-article:7650875pubmed:pagination399-401lld:pubmed
pubmed-article:7650875pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7650875pubmed:meshHeadingpubmed-meshheading:7650875-...lld:pubmed
pubmed-article:7650875pubmed:meshHeadingpubmed-meshheading:7650875-...lld:pubmed
pubmed-article:7650875pubmed:meshHeadingpubmed-meshheading:7650875-...lld:pubmed
pubmed-article:7650875pubmed:meshHeadingpubmed-meshheading:7650875-...lld:pubmed
pubmed-article:7650875pubmed:meshHeadingpubmed-meshheading:7650875-...lld:pubmed
pubmed-article:7650875pubmed:meshHeadingpubmed-meshheading:7650875-...lld:pubmed
pubmed-article:7650875pubmed:meshHeadingpubmed-meshheading:7650875-...lld:pubmed
pubmed-article:7650875pubmed:meshHeadingpubmed-meshheading:7650875-...lld:pubmed
pubmed-article:7650875pubmed:meshHeadingpubmed-meshheading:7650875-...lld:pubmed
pubmed-article:7650875pubmed:meshHeadingpubmed-meshheading:7650875-...lld:pubmed
pubmed-article:7650875pubmed:meshHeadingpubmed-meshheading:7650875-...lld:pubmed
pubmed-article:7650875pubmed:meshHeadingpubmed-meshheading:7650875-...lld:pubmed
pubmed-article:7650875pubmed:meshHeadingpubmed-meshheading:7650875-...lld:pubmed
pubmed-article:7650875pubmed:meshHeadingpubmed-meshheading:7650875-...lld:pubmed
pubmed-article:7650875pubmed:meshHeadingpubmed-meshheading:7650875-...lld:pubmed
pubmed-article:7650875pubmed:meshHeadingpubmed-meshheading:7650875-...lld:pubmed
pubmed-article:7650875pubmed:meshHeadingpubmed-meshheading:7650875-...lld:pubmed
pubmed-article:7650875pubmed:year1995lld:pubmed
pubmed-article:7650875pubmed:articleTitleStimulation of cyclic AMP formation by pituitary adenylate cyclase-activating polypeptide is attenuated by glutamate in rat brain slices.lld:pubmed
pubmed-article:7650875pubmed:affiliationDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Osaka University, Suita, Japan.lld:pubmed
pubmed-article:7650875pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7650875pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:7650875pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed